Core Laboratories NV (CLB)
Cash conversion cycle
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | ||
|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 46.98 | 6,486.80 | 6,919.66 | 6,994.45 |
| Days of sales outstanding (DSO) | days | 89.30 | 93.45 | 94.52 | 94.78 |
| Number of days of payables | days | 27.33 | 3,330.76 | 3,649.31 | 3,213.38 |
| Cash conversion cycle | days | 108.96 | 3,249.49 | 3,364.87 | 3,875.85 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 46.98 + 89.30 – 27.33
= 108.96
Core Laboratories NV's cash conversion cycle improved significantly throughout the year 2024. Starting at 3,875.85 days on March 31, 2024, the company managed to reduce it to 3,364.87 days by June 30, further decreasing to 3,249.49 days by September 30. However, the most notable improvement was seen by the end of the year, with the cash conversion cycle shrinking remarkably to just 108.96 days by December 31, 2024. This trend suggests that Core Laboratories NV became more efficient in managing its cash inflows and outflows, indicating potential enhancements in working capital management and liquidity.
Peer comparison
Dec 31, 2024